Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

by Carla M. Startin, Carla M. Startin, Carla M. Startin, Bryony Lowe, Bryony Lowe, Sarah Hamburg, Sarah Hamburg, Sarah Hamburg, Rosalyn Hithersay, Rosalyn Hithersay, Rosalyn Hithersay, Andre Strydom, Andre Strydom, Andre Strydom, LonDownS Consortium, Andre Strydom, Elizabeth Fisher, Dean Nizetic, John Hardy, Victor Tybulewicz, Annette Karmiloff-Smith
Published 2019-04-01

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome

by Laia Montoliu-Gaya, Andre Strydom, Kaj Blennow, Henrik Zetterberg, Nicholas James Ashton
Published 2021-08-01

The AT(N) framework for Alzheimer's disease in adults with Down syndrome

by Michael S. Rafii, Beau M. Ances, Nicole Schupf, Sharon J. Krinsky‐McHale, Mark Mapstone, Wayne Silverman, Ira Lott, William Klunk, Elizabeth Head, Brad Christian, Florence Lai, H. Diana Rosas, Shahid Zaman, Melissa E. Petersen, Andre Strydom, Juan Fortea, Benjamin Handen, Sid O'Bryant
Published 2020-01-01

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

by Carla M. Startin, Hana D’Souza, George Ball, Sarah Hamburg, Rosalyn Hithersay, Kate M. O. Hughes, Esha Massand, Annette Karmiloff-Smith, Michael S. C. Thomas, LonDownS Consortium, Andre Strydom
Published 2020-01-01

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

by Andre Strydom, Amanda Heslegrave, Carla M. Startin, Kin Y. Mok, John Hardy, Jurgen Groet, Dean Nizetic, Henrik Zetterberg, The LonDownS Consortium
Published 2018-04-01

Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome

by Diego Real de Asua, Miguel A. Mayer, María del Carmen Ortega, Jose M. Borrel, Teresa de Jesús Bermejo, Domingo González-Lamuño, Coral Manso, Fernando Moldenhauer, María Carmona-Iragui, Anke Hüls, Stephanie L. Sherman, Andre Strydom, Rafael de la Torre, Mara Dierssen
Published 2021-08-01

The importance of understanding individual differences in Down syndrome [version 1; referees: 2 approved]

by Annette Karmiloff-Smith, Tamara Al-Janabi, Hana D'Souza, Jurgen Groet, Esha Massand, Kin Mok, Carla Startin, Elizabeth Fisher, John Hardy, Dean Nizetic, Victor Tybulewicz, Andre Strydom
Published 2016-03-01

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

by Carla M. Startin, Carla M. Startin, Carla M. Startin, Sarah Hamburg, Sarah Hamburg, Sarah Hamburg, Andre Strydom, Andre Strydom, Andre Strydom, LonDownS Consortium
Published 2019-01-01

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome

by Sarah E. Pape, R. Asaad Baksh, Carla Startin, Sarah Hamburg, Rosalyn Hithersay, Andre Strydom
Published 2021-04-01

Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome

by Tomer Illouz, Tomer Illouz, Arya Biragyn, Maria Florencia Iulita, Maria Florencia Iulita, Maria Florencia Iulita, Lisi Flores-Aguilar, Mara Dierssen, Mara Dierssen, Mara Dierssen, Ilario De Toma, Ilario De Toma, Ilario De Toma, Stylianos E. Antonarakis, Stylianos E. Antonarakis, Stylianos E. Antonarakis, Eugene Yu, Eugene Yu, Yann Herault, Marie-Claude Potier, Alexandra Botté, Randall Roper, Benjamin Sredni, Jacqueline London, William Mobley, Andre Strydom, Andre Strydom, Eitan Okun, Eitan Okun, Eitan Okun
Published 2021-06-01

Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress.

by Panagiotis Zis, Patrick McHugh, Andrew McQuillin, Domenico Praticò, Mark Dickinson, Sima Shende, Zuzana Walker, Andre Strydom
Published 2014-01-01

The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population

by Sarah E. Pape, Tamara al Janabi, Nicholas J. Ashton, Abdul Hye, Rory Sheehan, Paul Gallagher, Bernice Knight, Anne-Marije Prins, Ken Courtenay, Vesna Jordanova, Bini Thomas, Nagarajan Perumal, Craig Forbes, Angela Hassiotis, Andre Strydom
Published 2021-06-01

Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome...

by Amanda Sinai, Angela Hassiotis, Khadija Rantell, Andre Strydom
Published 2016-01-01

Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase

by David Mengel, Wen Liu, Robert J. Glynn, Dennis J. Selkoe, Andre Strydom, Florence Lai, H. Diana Rosas, Amy Torres, Vasiliki Patsiogiannis, Brian Skotko, Dominic M. Walsh
Published 2020-03-01

Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

by Anke Hüls, Alberto C.S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole T. Baumer, Ana Claudia Brandão, Angelo Carfi, Maria Carmona-Iragui, Brian Allen Chicoine, Sujay Ghosh, Monica Lakhanpaul, Coral Manso, Miguel-Angel Mayer, Maria del Carmen Ortega, Diego Real de Asua, Anne-Sophie Rebillat, Lauren Ashley Russell, Giuseppina Sgandurra, Diletta Valentini, Stephanie L. Sherman, Andre Strydom
Published 2021-03-01